Clinical trial
Effect of Dosage Reduction of Glucose-Lowering Multidrug Regimens on the Incidence of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan: An Open-Label, Parallel-Group, Randomized, Controlled Trial
NCT04237493 is registered in ClinicalTrials.gov with University of Jordan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Dosage Reduction of Glucose-Lowering Multidrug Regimens on the Incidence of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan: An Open-Label, Parallel-Group, Randomized, Controlled Trial
- Lead sponsor
- University of Jordan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 14, 2017
- Completion date
- July 24, 2017
- Enrollment
- 687 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.